Virios Therapeutics, Inc. VIRI
Set alert
0.16 0.00 0.00%
At close · Oct 8
0.143 Day range 0.2068
52-week range unavailable
- Open
- 0.2068
- Prev close
- 0.155
- Mkt cap
- 206.50K
- Vol
- 42.36M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.143
- High
- 0.2068
- Forward P/E
- -0.97
- Beta
- 1.58
- Short ratio
- 0.64
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2024
- 50-d avg
- 4.51
- 200-d avg
- 7.69
- 1y target
- 3.00
Financial health
Altman Z-Score
-646.31 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.6×
FY 2018 5y median -5.4× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.3×
FY 2018 5y median 8.9× FY 2025
P/FCF -1.4×
FY 2018 5y median -55.4× FY 2025
EV/EBITDA 0.3×
FY 2018 5y median 0.3× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -70.7%
FY 2018 5y median -1.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -47.4%
FY 2018 5y median -110.1% FY 2025
ROIC -425867.5%
FY 2018 5y median -143.1% FY 2025
ROA -39.4%
FY 2018 5y median -101.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -128.7%
FY 2018 FY 2025
EPS (diluted) 43.1%
FY 2018 FY 2025
Free Cash Flow -77.7%
FY 2018 FY 2025
Financial Health
Current Ratio 0.0×
FY 2018 5y median 8.0× FY 2025
Quick Ratio 0.0×
FY 2018 5y median 8.0× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -0.1×
FY 2018 5y median -0.1× FY 2025
Interest Coverage -288519×
FY 2018 5y median -133× FY 2025
Dividends
Dividend Yield 5686.3%
FY 2018 5y median 0.0% FY 2025
Payout Ratio -3538.5%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31